THE NEUROSTEROID 3-ALPHA-HYDROXY-5-ALPHA-PREGNAN-20-ONE INDUCES CYTOARCHITECTURAL REGRESSION IN CULTURED FETAL HIPPOCAMPAL-NEURONS

被引:0
作者
BRINTON, RD
机构
关键词
NEUROSTEROIDS; PROGESTERONE METABOLITE STEROIDS; NERVE CELL GROWTH; HIPPOCAMPAL NEURONS; EPILEPSY; ESTROGEN;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one (3 alpha,5 alpha-THP) acts as a potent allosteric modulator and a direct activator of the GABA-chloride channel complex. This neurosteroid has also been found to protect against seizures that arise from blockade of the GABA-chloride channel complex. Because 3 alpha,5 alpha-THP protects against excitotoxin-induced seizure activity and because seizure activity has been found to be associated with aberrant hippocampal nerve cell growth, the rapid effect of the neurosteroid 3 alpha,5 alpha-THP upon nerve cell growth was investigated using videomicroscopy of hippocampal neurons in culture. Within 40 min of exposure 3(alpha,5 alpha-THP) induced a significant decrease in the area and length of neurites. A concomitant decrement in the number and length of filopodia decorating neuritic extensions also occurred within the 40 min of 3 alpha,5 alpha-THp exposure. Both rapid and slow retrograde movement of intracellular organelles was observed in 3 alpha,5 alpha-THP-treated neurons. 3 alpha,5 alpha-THPinduced regression of neuritic extensions occurred only in nerve cells that had not yet established contact with other nerve or glial cells in culture. Established structural connections between neurons or glia did not erode during 3 alpha,5 alpha-THP exposure. Neither the inactive stereoisomer 3 beta-hydroxy-5 beta-pregnan-20-one nor progesterone had a significant effect upon any of the morphological parameters assessed. In approximately 25% of the cells in which 3 alpha,5 alpha-THP had induced regression, subsequent exposure to 17 beta-estradiol induced profuse filopodial growth within 60 sec of exposure. In cultures similar in age to those used in the morphological studies, 3 alpha,5 alpha-THP induced a significant increase in Cl-36-uptake within 10 sec. The magnitude of Cl-36- uptake was comparable to that induced by exposure to 100 mu M GABA. In older, more mature cultures in which the nerve cells had established structural connections, 3 alpha,5 alpha-THP protected cells from picrotoxin-induced nerve cell death. These results demonstrate that 3 alpha,5 alpha-THP can induce regression of neuronal morphology within a relatively rapid time frame. 3 alpha,5 alpha-THP induction of Cl-36- uptake within 10 sec suggests that activation of neurosteroid-regulated chloride channels is an initial step in the biochemical mechanism underlying the retraction induced by this progesterone metabolite steroid. In select instances, 17 beta-estradiol induced an extremely rapid reversal of the filopodial regression produced by 3 alpha,5 alpha-THP. Collectively, these findings indicate that steroid factors acting singly and in combination can induce significant changes in nerve cell morphology within a time frame that is consistent with 3 alpha,5(alpha-THP and 17 beta-estradiol regulation of excitability.
引用
收藏
页码:2763 / 2774
页数:12
相关论文
共 84 条
[1]  
ALETTA JM, 1988, J NEUROSCI, V8, P1425
[2]   GONADAL-STEROID INDUCTION OF STRUCTURAL SEX-DIFFERENCES IN THE CENTRAL NERVOUS-SYSTEM [J].
ARNOLD, AP ;
GORSKI, RA .
ANNUAL REVIEW OF NEUROSCIENCE, 1984, 7 :413-442
[3]   ORGANIZATIONAL AND ACTIVATIONAL EFFECTS OF SEX STEROIDS ON BRAIN AND BEHAVIOR - A REANALYSIS [J].
ARNOLD, AP ;
BREEDLOVE, SM .
HORMONES AND BEHAVIOR, 1985, 19 (04) :469-498
[4]  
Backstrom T, 1985, Acta Obstet Gynecol Scand Suppl, V130, P19
[5]   TROPHIC FACTORS AND NEURONAL SURVIVAL [J].
BARDE, YA .
NEURON, 1989, 2 (06) :1525-1534
[6]  
BARKER JL, 1986, J PHYSIOL-LONDON, V377, pP83
[7]  
BARTLETT W, 1984, J NEUROSCI, V4, P1964
[8]   NEUROSTEROIDS - A NEW BRAIN-FUNCTION [J].
BAULIEU, EE ;
ROBEL, P .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 37 (03) :395-403
[9]  
BAULIEU EE, 1991, FIDIA RES F S SERIES, V8, P135
[10]  
BELELLI D, 1989, EUR J PHARMACOL, V166, pL325